AAAAAA

   
Results: 1-11 |
Results: 11
Delayed adjuvant tamoxifen: Ten-year results of a collaborative randomizedcontrolled trial in early breast cancer (TAM-02 trial)
Authors: Delozier, T Switsers, O Genot, JY Ollivier, JM Hery, M Namer, M Fresney, M Kerbrat, P Veyret, C de Lafontan, B Janvier, M Mace-Lesech, J
Citation: T. Delozier et al., Delayed adjuvant tamoxifen: Ten-year results of a collaborative randomizedcontrolled trial in early breast cancer (TAM-02 trial), ANN ONCOL, 11(5), 2000, pp. 515-519
Leukemias and preleukemic states developing after treatment of breast cancer
Authors: Cutuli, B Janvier, M de la Rochefordiere, A Julien, JP Isambert, N Alzieu, C Kerbrat, P de Lafontan, B van Lemmens, L Cure, H Ganem, G Baume, D Le Mevel, A Lorthoraly, A de Gislain, C Marchal, C Chevelle, C Lauche, H Serin, D
Citation: B. Cutuli et al., Leukemias and preleukemic states developing after treatment of breast cancer, PRESSE MED, 29(3), 2000, pp. 135-138
High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: Does impact on quality of life jeopardize feasibility and acceptability of treatment?
Authors: Macquart-Moulin, G Viens, P Palangie, T Bouscary, ML Delozier, T Roche, H Janvier, M Fabbro, M Moatti, JP
Citation: G. Macquart-moulin et al., High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: Does impact on quality of life jeopardize feasibility and acceptability of treatment?, J CL ONCOL, 18(4), 2000, pp. 754-764
Tamoxifen adjuvant treatment duration in early breast cancer: Initial results of a randomized study comparing short-term treatment with long-term treatment
Authors: Delozier, T Spielmann, M Mace-Lesec'h, J Janvier, M Hill, C Asselain, B Julien, JP Weber, B Mauriac, L Petit, JC Kerbrat, P Malhaire, JP Vennin, P Leduc, B Namer, M
Citation: T. Delozier et al., Tamoxifen adjuvant treatment duration in early breast cancer: Initial results of a randomized study comparing short-term treatment with long-term treatment, J CL ONCOL, 18(20), 2000, pp. 3507-3512
High-dose chemotherapy with autologous hematopoietic stem cell support formetastatic breast cancer: Results of the French Pegase 04 protocol
Authors: Lotz, JP Cure, H Janvier, M Morvan, F Legros, M Asselain, B Guillemot, M Roche, H Gisselbrecht, C
Citation: Jp. Lotz et al., High-dose chemotherapy with autologous hematopoietic stem cell support formetastatic breast cancer: Results of the French Pegase 04 protocol, HEM CELL TH, 41(2), 1999, pp. 71-74
Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: A GELA study
Authors: Coiffier, B Neidhardt-Berard, EM Tilly, H Belanger, C Bouabdallah, R Haioun, C Brice, P Peaud, PY Pico, JL Janvier, M Solal-Celigny, P Brousse, N
Citation: B. Coiffier et al., Fludarabine alone compared to CHVP plus interferon in elderly patients with follicular lymphoma and adverse prognostic parameters: A GELA study, ANN ONCOL, 10(10), 1999, pp. 1191-1197
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)
Authors: Thomas, X Fenaux, P Dombret, H Delair, S Dreyfus, F Tilly, H Vekhoff, A Cony-Makhoul, P Leblond, V Troussard, X Cordonnier, C de Revel, T Simon, M Nicolini, F Stoppa, AM Janvier, M Bordessoule, D Rousselot, P Ffrench, M Marie, JP Archimbaud, E
Citation: X. Thomas et al., Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial), LEUKEMIA, 13(8), 1999, pp. 1214-1220
A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes
Authors: Wattel, E Solary, E Leleu, X Dreyfus, F Brion, A Jouet, JP Hoang-Ngoc, L Maloisel, F Guerci, A Rochant, H Gratecos, N Casassus, P Janvier, M Brice, P Lepelley, P Fenaux, P
Citation: E. Wattel et al., A prospective study of autologous bone marrow or peripheral blood stem cell transplantation after intensive chemotherapy in myelodysplastic syndromes, LEUKEMIA, 13(4), 1999, pp. 524-529
Characterization of Methylophaga species by rRNA gene restriction patterns(ribotyping)
Authors: Janvier, M Grimont, RAD Grimont, F
Citation: M. Janvier et al., Characterization of Methylophaga species by rRNA gene restriction patterns(ribotyping), SYST APPL M, 22(3), 1999, pp. 372-377
First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial)
Authors: Viens, P Palangie, T Janvier, M Fabbro, M Roche, H Delozier, T Labat, JP Linassier, C Audhuy, B Feuilhade, F Costa, B Delva, R Cure, H Rousseau, F Guillot, A Mousseau, M Ferrero, JM Bardou, VJ Jacquemier, J Pouillart, P
Citation: P. Viens et al., First-line high-dose sequential chemotherapy with rG-CSF and repeated blood stem cell transplantation in untreated inflammatory breast cancer: toxicity and response (PEGASE 02 trial), BR J CANC, 81(3), 1999, pp. 449-456
Successful cryopreservation of purified autologous CD34(+) cells: influence of freezing parameters on cell recovery and engraftment
Authors: Beaujean, F Bourhis, JH Bayle, C Jouault, H Divine, M Rieux, C Janvier, M Le Forestier, C Pico, JL
Citation: F. Beaujean et al., Successful cryopreservation of purified autologous CD34(+) cells: influence of freezing parameters on cell recovery and engraftment, BONE MAR TR, 22(11), 1998, pp. 1091-1096
Risultati: 1-11 |